Pear Therapeutics recently announced that FDA granted authorization for Somryst, the first prescription digital therapeutic (PDT) to treat adult patients with chronic insomnia.
Somryst is a nine-week...
The Bill and Melinda Gates Foundation, Wellcome, and Mastercard recently launched an initiative to boost drug discovery and biologics to treat patients with COVID-19.
For more coronavirus updates,...
The US Senate has voted to confirm Stephen Hahn, MD, the former chief medical executive for MD Anderson Cancer Center in Texas, as the new commissioner for the Food and Drug Administration (FDA).
In a...
